Skip to content

Evaluation of the Application of Abdominal Endoscopic Surgical System in Urology Surgery

Evaluation of the Application of Abdominal Endoscopic Surgical System in Urology Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094197
Enrollment
Unknown
Registered
2024-12-18
Start date
2023-11-29
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Test group:Surgery completed with the assistance of experimental instruments

Sponsors

Harbin Sizherui Intelligent Medical Equipment Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18-80 years old (inclusive), male or female; 2.BMI:18-30kg/m2; 3. There are relevant indications for urological surgery; 4. Those whose physiological condition can undergo laparoscopic surgery; 5. Willing to cooperate with and complete the study follow-up and related examinations; 6. Those who voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have severe cardiovascular or circulatory disease and cannot tolerate surgery; 2. Pregnancy or lactation; 3. Have a history of epilepsy or psychiatric illness; 4. People with severe allergies and suspected or confirmed alcohol or drug addiction; 5. Inability to understand the study requirements or inability to complete the study follow-up plan; 6. Those who have participated in other investigational drugs or devices and have not completed clinical trials; 7. Those who are considered inappropriate by the investigator to participate in this study.

Design outcomes

Primary

MeasureTime frame
Untransmission rate during surgery;Manipulator operation time;

Secondary

MeasureTime frame
Surgical satisfaction;

Countries

China

Contacts

Public ContactWanhai Xu

Cancer Hospital Affiliated to Harbin Medical University

17316070157@163.com+86 173 6739 3734

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026